|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash Flows From Operating Activities | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||
| Depreciation and amortization of intangible assets | ||||
| Amortization and write-off of debt premiums, discounts and issuance costs | ||||
| Asset impairments | ||||
| Acquisition-related contingent consideration | ||||
| Allowances for losses on trade receivables and inventories | ||||
| Deferred income taxes | ||||
| Additions (payments) to accrued legal settlements | ||||
| Gain on sale of assets | ||||
| Share-based compensation | ||||
| Foreign exchange gain | ||||
| Gain excluded from hedge effectiveness | ||||
| Loss on extinguishment of debt | ||||
| Amortization of inventory step-up resulting from acquisitions | ||||
| Other | ||||
| Changes in operating assets and liabilities: | ||||
| Trade receivables | ||||
| Inventories | ||||
| Prepaid expenses and other current assets | ||||
| Accounts payable, accrued and other liabilities | ||||
| Net cash provided by (used in) operating activities | ||||
| Cash Flows From Investing Activities | ||||
| Acquisitions and other investments | ||||
| Purchases of property, plant and equipment | ||||
| Purchases of marketable securities | ||||
| Proceeds from sale of marketable securities | ||||
| Proceeds from sale of assets and businesses, net of costs to sell | ||||
| Interest settlements from cross-currency swaps | ||||
| Net cash used in investing activities | ||||
| Cash Flows From Financing Activities | ||||
| Issuance of long-term debt, net of discounts, and other financial liabilities | ||||
| Repayments of debt | ||||
| Payment of employee withholding taxes related to share-based awards | ||||
| Payments of financing costs | ||||
| Payments of noncontrolling interest distributions | ||||
| Net borrowings under BHC pooled financing arrangements (Note 3) | ||||
| Net transfers to BHC (Note 3) | ||||
| Other | ||||
| Net cash provided by financing activities | ||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | ||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | ||||
| Cash and cash equivalents and restricted cash, beginning of period | ||||
| Cash and cash equivalents and restricted cash, end of period | ||||
| Non-cash Investing Activities | ||||
| Accrued purchases of property, plant and equipment | ||||
| Issuance of BHC Purchase Debt (Note 3) | ||||
Loading...